Photodynamic therapy (PDT) as a new non-invasive treatment modality for infection, tumor and other diseases has attracted widespread attention due to high spatiotemporal selectivity, minimal side effects and low systemic toxicity over the last few decades [
4–
6]. During the process of PDT, photosensitizers (PSs) and light were employed to sensitize adjacent normal oxygen (
3O
2) to generate singlet oxygen (
1O
2) or other types of reactive oxygen species (ROS)
via energy transfer or electron transfer of the excited triplet PSs, respectively [
7]. The highly reactive ROS can cause irreversible damages to bacteria by chemical oxidation, so that it is scarcely possible for bacteria to develop resistance to PDT [
8]. As far as we know, the treatment outcome of PDT is closely related to the PS employed,
i.e., effective PSs with high ROS sensitizing efficiency and target specificity greatly favor the PDT applications [
9]. Traditional PSs (
e.g., porphyrins, BODIPY, phenothiazinium salts, cyanines) have been widely applied in the field of photodynamic antibacterial and anticancer agents [
10–
12]. However, these PSs are usually featured with giant hydrophobic coplanar structures, and inclined to experience strong
π-
π interactions at high concentrations or in the aggregated state, which will result in distinct fluorescence quenching and reduced ROS sensitizing efficiency owing to the decay of the excited state energy
via non-radiative pathways [
13], thus severely limiting their applications in both imaging and PDT therapy. In comparison, PSs with aggregation-induced emission (AIE) properties, which exhibit both enhanced emission and elevated photosensitization efficiency in the aggregated state or even in aqueous media as a result of restricted intramolecular motions, have recently emerged as a class of promising candidates [
14]. To date, a large number of AIE PSs have been successfully developed to kill bacteria [
15–
19]. Detailed studies have revealed that the bactericidal efficiency of these AIE PSs can be remarkably enhanced when a positively charged AIE PS binds to the bacteria
via electrostatic interactions [
20], which is attributed to the short lifetimes and small effective working radii of ROS [
21]. According to the structural features of the phospholipid bilayer of the bacterial membrane,
i.e., the negatively charged "polar head" and the "non-polar tail" of phospholipid, exploring an amphiphilic AIE PS with membrane-targeting capabilities through electrostatic and hydrophobic interactions is highly desirable for higher antibacterial efficiency.